Hyperpolarized MRI using d-DNP is particularly beneficial for in vivo studies of 13 C-labelled metabolites, enabling live tracking of chemical conversion to downstream metabolites.

Hyperfine announces it has received CE Marking and UK Conformity Assessment (UKCA) approval for its Optive AI™ software ...

“What we found is that there is a 79 per cent percent reduction in the harms of the prostate cancer diagnostic process – ...

Bruker Corporation today announced the introduction of its groundbreaking dissolution Dynamic Nuclear Polarization (d-DNP) Polarizer at the 2025 Hyperpolarized Carbon-13 MRI Technology Development ...